BioMarin Pharmaceutical Inc.
- BMRN
- NASDAQ
- Biotechnology
- Rare Disease Therapeutics
- Enzyme Replacement Therapy
$54.68
Today −2.44%Quote Oct 16, 2026, 08:00 PM UTC
−15.98%over the last month
Max drawdown −16.4%From 1-month high −16.0%3 months −7.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$10.58B
Quote Oct 16
Next earnings
Oct 26
Expected, not confirmed
Analyst target
$91.06
+66.5% from here
Floor
$54.04
1.2% below price
Where the price sits
41 analysts
Analyst range, low to high
$59.00$124.00
- Price $54.68
- Resistance $55.60
- Consensus $91.06
The price is just above its floor and right under resistance. Analysts' average target sits about 67% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BMRNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $989.7M
- Product$984.4M99.5%
- Royalty And Other$5.3M0.5%
Industry
Biotechnology
Employees
3,221